Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Cancer Res Treat > Volume 44(1); 2012 > Article
Special Article Prediction of Cancer Incidence and Mortality in Korea, 2012
Kyu-Won Jung, MS1, Sohee Park, PhD1, Young-Joo Won, PhD1, Hyun-Joo Kong, MS1, Joo Young Lee, MD1, Hong Gwan Seo, MD, PhD2, Jin-Soo Lee, MD, PhD1
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2012;44(1):25-31.
DOI: https://doi.org/10.4143/crt.2012.44.1.25
Published online: March 31, 2012

1The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, Korea.

2National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Correspondence: Sohee Park, PhD. The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2015, Fax: 82-31-920-2179, shpark@ncc.re.kr
• Received: March 2, 2012   • Accepted: March 5, 2012

Copyright © 2012 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 13,807 Views
  • 71 Download
  • 69 Crossref
  • 61 Scopus
prev next
Full Article

Download PDF Download PDF

  • Purpose
    To estimate the current cancer burden in Korea, cancer incidence and mortality rates were projected for the year 2012.
  • Materials and Methods
    The cancer incidence data from 1999 to 2009 were obtained from the Korea National Cancer Incidence Database, and the cancer mortality data from 1993 to 2010 were obtained from Statistics Korea. Cancer incidence in 2012 was projected by fitting a linear regression model on observed age-specific cancer incidence rates against observed years, then multiplying the projected age-specific rates by the age-specific population. For cancer mortality, a similar procedure was applied, except that a Joinpoint regression model was used to determine at which year the linear trend significantly changed.
  • Results
    A total of 234,727 new cancer cases and 73,313 cancer deaths are projected to occur in Korea in 2012. For all sites combined, the crude incidence rates are projected to be 465.6 and 459.7, and the age-standardized incidences to be 345.1 and 300.9 per 100,000 respectively for males and females.
  • Conclusion
    Cancer has become an important public health concern in Korea, and as the Korean population ages, the cancer burden will continue to increase.
  • Key words: Incidence, Mortality, Neoplasms, Prediction, Korea, 2012
Since 1983, as the leading cause of death [1], cancer has become a major public health concern in Korea. Annually, over 190,000 patients are newly diagnosed with cancer in Korea, and one out of four deaths is due to cancer [2,3]. Although the cancer registration system in Korea is very efficient and can provide nationwide cancer statistics within a relatively short time, at least a 2-year lag is still required for accurate data collection and compilation. To plan and apply a cancer control program, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this report, we provide the projected cancer incidence and mortality ratio based on the data up to 2009.
The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry (the Korea Central Cancer Registry [KCCR]) in 1980. The details of the history, objectives, and activities of the KCCR have been documented elsewhere [4]. Incidence data from 1999 to 2009 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [5] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [6].
Mortality data from 1993 to 2010 were obtained from Statistics Korea [1]. The cause of death was coded and classified according to ICD-10.
The cancer sites included in this report are (i) all cancers combined and (ii) the 22 most common cancers: lip, month, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of biliary tract (gallbladder) (C23-C24), pancreas (C25), lung and bronchus (lung) (C33-C34), breast (C50), uterine cervix (C53), uterine corpus (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C85, C96), multiple myeloma (C90), leukemia (C91-C95), and all others.
Population data were obtained from the resident registration population reported by Statistics Korea. The mid-year population on July 1 of the respective year was applied when computing the incidence and deaths.
Due to the time required for data collection and analysis, incidence and mortality data are available is usually 2-3 years behind the current year. As such, we projected the expected number of new cancer cases and deaths in Korea in the current year to provide an estimate of the current cancer burden.
Linear regression models [7] were used to assess the time trend and the projection of rates. Based on the observed cancer incidence data, a linear regression model was fitted to the age-specific rates by 5-year age group against observed years. From the projected age-specific rates in 2012, the estimated number of cancer cases was calculated by multiplying the rates by 2012's projected age-specific population size. For thyroid and prostate cancer, which showed significant curvilinear trends, we used a square root transformation when fitting a linear regression model and converted the predicted values back to the original scale.
To estimate the number of cancer deaths in 2012, we first ran a Joinpoint regression model on the data for 1993-2010 to detect the year of significant changes in the trend of cancer mortality by sex and cancer site. A Joinpoint regression describes changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using the Joinpoint software (version 3.3, http://srab.cancer.gov/joinpoint) from the Surveillance Research Program of the National Cancer Institute in the USA [8]. After identifying the year of significant trend changes using Joinpoint regression analysis, a simple linear regression model was fitted to the last line segment to estimate age-specific cancer mortality rates in 2012. Similar to the method used for the projection of cancer incidence, the number of new deaths was then projected by multiplying the age-specific cancer mortality rates by 2012's projected age-specific population.
We summarized the results using the crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. The ASRs were standardized using the World Health Organization (WHO) world standard population [9].
1. Incidence
Table 1 presents the estimated number of new cancer cases and deaths during 2012 in Korea by sex and cancer site. It is projected that 234,727 cases of cancer incidence will occur in 2012.
Table 2 presents the estimated CRs and ASRs of cancer incidence in 2012 by sex and cancer site. The CRs of all sites combined in males and females respectively in 2012 are projected to be 465.6 and 459.7 per 100,000, and the ASRs of all sites combined are projected to be 345.1 and 300.9 per 100,000. In males, the five leading primary sites of cancer are expected to be the stomach (CR, 86.8; ASR, 63.2), colon and rectum (CR, 77.4; ASR, 56.7), lung (CR, 62.9; ASR, 46.6), liver (CR, 49.5; ASR, 35.6), and prostate (CR, 43.4; ASR, 32.5), accounting for 68.7% of all newly diagnosed cancers in 2012. In females, the most common cancer sites are expected to be thyroid (CR, 153.4; ASR, 109.4), breast (CR, 64.6; ASR, 44.1), colon and rectum (CR, 49.5; ASR, 29.5), stomach (CR, 41.1; ASR, 24.7), lung (CR, 26.6; ASR, 14.7), and liver (CR, 17.1; ASR, 10.0), accounting for 76.7% of all newly diagnosed cancers (Fig. 1). Thyroid cancer alone is projected to account for 33.4% (38,863 cases) of incident cases in females in 2012.
Table 3 presents the most common cancer sites expected in 2012 by sex and age group. Leukemia and thyroid cancer are projected to be the most common forms of cancer in both sexes for the 0-14 and 15-34 age groups. Gastric cancer is predicted to be the most common cancer in males 35-64 years of age, whereas lung cancer is predicted to be more frequent for malese ≥65 years of age. Thyroid cancer is predicted to be the most common cancer for females 35-64 years of age, whereas colorectal cancer is predicted to be the most common cancer for females ≥65 years of age. Fig. 2 shows the age-specific incidence rates of the selected cancers for men and women in 2012. The projection indicates that the incidence of gastric, lung, liver, and colorectal cancers will increase gradually with age. In women, the age-specific incidence rates of breast and thyroid cancer will increase with age until the 5th and 6th decades of life, and then level off.
2. Mortality
It is estimated that 73,313 cancer deaths will occur in Korea during 2012 (Table 1). The CRs of all sites combined in 2012 respectively for males and females are projected to be 178.5 and 110.4 per 100,000, and the ASRs of all sites combined are expected to be 135.8 and 59.0 per 100,000 (Table 4).
In 2012, the five leading cancer sites causing mortality in males are predicted to be lung (CR, 46.5; ASR, 34.4), liver (CR, 32.2; ASR, 23.5), stomach (CR, 22.2; ASR, 16.4), colon and rectum (CR, 18.3; ASR, 13.7), and pancreas (CR, 9.6; ASR, 7.1). During the same time period, in females, lung cancer (CR, 17.2; ASR, 8.7) is projected to be the leading cancer site causing mortality, followed by cancers of the colon and rectum (CR, 14.0; ASR, 7.1), stomach (CR, 12.1; ASR, 6.1), liver (CR, 11.0; ASR, 6.0), and pancreas (CR, 8.8; ASR, 4.5).
Fig. 3 shows the age-specific predicted mortality rates of the selected cancers for males and females in 2012. When examined by age, Korean males >60 years of age are expected to have the highest mortality rates from liver cancer, followed by lung cancer. In contrast, Korean females >55 years of age are expected to have the highest mortality rates from breast cancer, followed by lung cancer.
This report provides the estimated nationwide cancer incidence and mortality in Korea for the current year. A total of 234,727 new cancer cases and 73,313 cancer deaths are expected in Korea during 2012. In Korean males, gastric, colorectal, lung, liver, and prostate cancers are estimated to have the highest rates of incidence, while lung, liver, gastric, colorectal, and pancreatic cancers are estimated to be the most common causes of cancer-related deaths. In Korean females, thyroid, breast, colorectal, gastric, and lung cancer are estimated to have the highest rates of incidence, while lung, colorectal, stomach, liver, and pancreas cancers are estimated to be the most common causes of cancer-related deaths.
Cancer has become an important public health concern in Korea, and as the population continues to age, the cancer burden will continue to increase. The estimated cancer statistics of the current year given in this report represent an important resource to plan and evaluate cancer-control programs. The estimates in this report, however, are projected numbers based on statistical models and may vary from year to year; hence, these estimates should be used with caution.
Acknowledgements
This work was supported by a research grant from the National Cancer Center (No. 1010160) and National Health Promotion Program grants (Nos. 1160390 and 1160400) from the Ministry of Health and Welfare, Republic of Korea.

Conflict of interest relevant to this article was not reported.

  • 1. Statistics Korea, 2012 [Internet]. 2012. cited 2012 Jan 14Daejeon: Statistics Korea; Available from: http://kostat.go.kr
  • 2. Ministry of Health and Welfare2009 annual report of cancer statistics in Korea. 2011. Seoul: Ministry of Health and Welfare.
  • 3. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122–131. PMID: 19809561ArticlePubMedPMCPDF
  • 4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–331. PMID: 19956367ArticlePubMedPMCPDF
  • 5. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 2000. 3rd ed. Geneva: World Health Organization.
  • 6. World Health OrganizationManual of the international statistical classification of diseases, injuries, and causes of death. 1992. 10th rev. Geneva: World Health Organization.
  • 7. Boyle P, Parkin DM. . In: Jensen OM, Parkin DM, MacLennnan R, Muir CS, Skeet RG, editors. Statistical methods for registries. Cancer registration: principles and methods. IARC Scientific Publication No. 95. 1991. Lyon: IARC; p. 126–158.
  • 8. Joinpoint Regression Program, version 3.3 [Internet]. National Cancer Institute. 2012. cited 2012 Jan 6Bethesda, MD: National Cancer Institute; Available from: http://srab.cancer.gov/joinpoint/
  • 9. Segi M. Cancer Mortality for selected sites in 24 countries (1950-1957). 1960. Sendai: Tohoku University School of Medicine.
Fig. 1
The 10 leading types of estimated new cancer cases and deaths by gender in 2012. (A) Estimated new cases. (B) Estimated deaths.
crt-44-25-g001.jpg
Fig. 2
Projected age-specific incidences of major cancers during 2012 in Korea. (A) Male. (B) Female.
crt-44-25-g002.jpg
Fig. 3
Projected age-specific mortality rates of major cancers during 2012 in Korea. (A) Male. (B) Female.
crt-44-25-g003.jpg
Table 1
Estimated new cancer cases and deaths by gender during 2012 in Korea
Sites Estimated new cases
 Estimated deaths
Both genders Male Female Both genders Male Female
All sites 234,727 118,304 116,423 73,313 45,356 27,957
Lip, oral cavity, and pharynx 2,801 2,102 699 1,024 754 270
Esophagus 2,262 2,075 187 1,223 1,139 84
Stomach 32,455 22,054 10,401 8,685 5,630 3,055
Colon and rectum 32,215 19,669 12,546 8,195 4,648 3,547
Liver 16,910 12,585 4,325 10,973 8,186 2,787
Gallbladdera) 5,481 2,697 2,784 3,884 1,879 2,005
Pancreas 5,396 2,911 2,485 4,663 2,445 2,218
Larynx 1,077 1,036 41 226 210 16
Lung 22,737 15,991 6,746 16,168 11,819 4,349
Breast 16,436 63 16,373 2,146 16 2,130
Cervix uteri 3,292 - 3,292 819 - 19
Corpus uteri 2,085 - 2,085 259 - 259
Ovary 2,124 - 2,124 987 - 987
Prostate 11,016 11,016 - 1,540 1,540 -
Testis 215 215 - 18 18 -
Kidney 4,310 2,949 1,361 846 558 288
Bladder 3,969 3,185 784 1,026 737 289
Brain and CNS 1,837 975 862 1,061 575 486
Thyroid 46,021 7,158 38,863 360 100 260
Hodgkin lymphoma 253 160 93 41 26 15
Non-Hodgkin lymphoma 4,506 2,502 2,004 1,493 865 628
Multiple myeloma 1,236 648 588 841 424 417
Leukemia 2,885 1,609 1,276 1,676 964 712
Other and ill defined 13,208 6,704 6,504 5,159 2,823 2,336

CNS, central nervous system. a)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 2
Estimated crude and age-standardized cancer incidences by gender during 2012 in Korea
Estimated crude and age-standardized cancer incidences by gender during 2012 in Korea
Crude incidence rates/100,000
 Age-standardized incidence rates/100,000a)
Both genders Male Female Both genders Male Female
All sites 462.7 465.6 459.7 312.5 345.1 300.9
Lip, oral cavity, and pharynx 5.5 8.3 2.8 3.8 6.0 1.9
Esophagus 4.5 8.2 0.7 2.9 6.1 0.4
Stomach 64.0 86.8 41.1 42.1 63.2 24.7
Colon and rectum 63.5 77.4 49.5 41.9 56.7 29.5
Liver 33.3 49.5 17.1 22.0 35.6 10.0
Gallbladderb) 10.8 10.6 11.0 6.7 7.9 5.7
Pancreas 10.6 11.5 9.8 6.7 8.4 5.3
Larynx 2.1 4.1 0.2 1.4 3.0 0.1
Lung 44.8 62.9 26.6 28.2 46.6 14.7
Breast 32.4 0.2 64.6 22.2 0.2 44.1
Cervix uteri 6.5 - 13.0 4.4 - 8.5
Corpus uteri 4.1 - 8.2 2.8 - 5.5
Ovary 4.2 - 8.4 3.0 - 5.8
Prostate 21.7 43.4 - 14.1 32.5 -
Testis 0.4 0.8 - 0.4 0.8 -
Kidney 8.5 11.6 5.4 5.9 8.5 3.5
Bladder 7.8 12.5 3.1 4.9 9.2 1.6
Brain and CNS 3.6 3.8 3.4 3.1 3.4 2.7
Thyroid 90.7 28.2 153.4 64.5 20.1 109.4
Hodgkin lymphoma 0.5 0.6 0.4 0.4 0.5 0.3
Non-Hodgkin lymphoma 8.9 9.8 7.9 6.4 7.7 5.4
Multiple myeloma 2.4 2.6 2.3 1.6 1.9 1.4
Leukemia 5.7 6.3 5.0 5.1 6.0 4.4
Other and ill defined 26.0 26.4 25.7 18.1 20.7 15.9

CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

Table 3
Estimated cancer incidence by age group and sex during 2012 in Korea
Rank Age group (yr)
0-14 15-34 35-64 ≥65
Male
1 Leukemia Thyroid Stomach Lung
(4.9) (12.2) (98.2) (479.0)
2 Brain and CNS Leukemia Colon and rectum Stomach
(2.4) (3.2) (86.6) (449.8)
3 Non-Hodgkin lymphoma Non-Hodgkin lymphoma Liver Colon and rectum
(1.8) (2.9) (65.9) (404.0)
4 Kidney Colon and rectum Thyroid Prostate
(0.5) (2.8) (47.9) (350.5)
5 Testis Stomach Lung Liver
(0.4) (2.5) (41.3) (207.2)
Female
1 Leukemia Thyroid Thyroid Colon and rectum
(4.0) (68.5) (272.4) (198.8)
2 Brain and CNS Breast Breast Stomach
(2.0) (11.2) (119.4) (154.9)
3 Non-Hodgkin lymphoma Cervix uteri Colon and rectum Lung
(1.0) (4.9) (49.9) (129.8)
4 Ovary Stomach Stomach Thyroid
(0.7) (4.3) (43.1) (96.5)
5 Kidney Colon and rectum Lung Liver
(0.5) (2.7) (20.6) (76.7)

CNS, central nervous system.

Table 4
Estimated crude and age-standardized cancer mortality rates by gender during 2012 in Korea
Sites Crude incidence rates/100,000
 Age-standardized incidence rates/100,000a)
Both genders Male Female Both genders Male Female
All sites 144.5 178.5 110.4 89.7 132.8 59.0
Lip, oral cavity, and pharynx 2.0 3.0 1.1 1.3 2.1 0.6
Esophagus 2.4 4.5 0.3 1.5 3.3 0.1
Stomach 17.1 22.2 12.1 10.4 16.4 6.1
Colon and rectum 16.2 18.3 14.0 9.8 13.7 7.1
Liver 21.6 32.2 11.0 14.0 23.5 6.0
Gallbladderb) 7.7 7.4 7.9 4.5 5.5 3.8
Pancreas 9.2 9.6 8.8 5.7 7.1 4.5
Larynx 0.4 0.8 0.1 0.3 0.6 0.0
Lung 31.9 46.5 17.2 19.3 34.4 8.7
Breast 4.2 0.1 8.4 2.8 0.0 5.4
Cervix uteri 1.6 - 3.2 1.0 - 1.8
Corpus uteri 0.5 - 1.0 0.3 - 0.6
Ovary 1.9 - 3.9 1.2 - 2.3
Prostate 3.0 6.1 - 1.7 4.7 -
Testis 0.0 0.1 - 0.0 0.1 -
Kidney 1.7 2.2 1.1 1.0 1.6 0.6
Bladder 2.0 2.9 1.1 1.1 2.2 0.5
Brain and CNS 2.1 2.3 1.9 1.5 1.8 1.3
Thyroid 0.7 0.4 1.0 0.4 0.3 0.5
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 2.9 3.4 2.5 1.9 2.6 1.3
Multiple myeloma 1.7 1.7 1.6 1.0 1.2 0.9
Leukemia 3.3 3.8 2.8 2.4 3.0 1.9
Other and ill defined 10.2 11.1 9.2 6.4 8.4 5.0

CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • The feasibility and efficacy of perioperative auricular acupuncture technique via intradermal needle buried for postoperative movement-evoked pain after open radical gastrectomy: A randomized controlled pilot trial
      Xiao-Qing Wang, Lei Xiao, Pei-Bei Duan, Qian Xu, Li-Hua Yang, A-Qin Wang, Yan Wang
      EXPLORE.2022; 18(1): 36.     CrossRef
    • Air Pollution and Incidence of Lung Cancer by Histological Type in Korean Adults: A Korean National Health Insurance Service Health Examinee Cohort Study
      Da Hye Moon, Sung Ok Kwon, Sun-Young Kim, Woo Jin Kim
      International Journal of Environmental Research and Public Health.2020; 17(3): 915.     CrossRef
    • Tailored Biofunctionalized Biosensor for the Label-Free Sensing of Prostate-Specific Antigen
      Sachin Mishra, Eun-Seong Kim, Parshant Kumar Sharma, Zhi-Ji Wang, Sung-Hyun Yang, Ajeet Kumar Kaushik, Cong Wang, Yang Li, Nam-Young Kim
      ACS Applied Bio Materials.2020; 3(11): 7821.     CrossRef
    • Predicting Factors of Mammography Adherence among Iranian Women Based on Transtheoretical Model
      mahsa khodayarian, Tahmineh farajkhoda, Azita Aryaeenezhad, Mozhgan Sharifi
      Journal of Research Development in Nursing and Midwifery.2020; 17(2): 28.     CrossRef
    • Educational Data Mining Techniques Approach to Predict Student’s Performance
      Annisa Uswatun Khasanah, Harwati
      International Journal of Information and Education Technology.2019; 9(2): 115.     CrossRef
    • Incidence and mortality of stomach cancer in Shandong Province in 2012
      Zhentao Fu, Guigang Li, Jandong Sun, Yuting Zhai, Jiyu Zhang, Zilong Lu, Jie Chu, Gaohui Zhang, Xiaolei Guo, Aiqiang Xu
      Precision Radiation Oncology.2018; 2(1): 15.     CrossRef
    • Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer
      Jong-Young Lee, Seok Joong Yun, Pildu Jeong, Xuan-Mei Piao, Ye-Hwan Kim, Jihye Kim, Sathiyamoorthy Subramaniyam, Young Joon Byun, Ho Won Kang, Sung Phil Seo, Jayoung Kim, Jung Min Kim, Eun Sang Yoo, Isaac Y. Kim, Sung-Kwon Moon, Yung Hyun Choi, Wun-Jae Ki
      Oncotarget.2018; 9(45): 27656.     CrossRef
    • Polyphenolic compounds from Korean Lonicera japonica Thunb. induces apoptosis via AKT and caspase cascade activation in A549 cells
      Kwang Il Park, Hyeonsoo Park, Arulkumar Nagappan, Gyeong Eun Hong, Silvia Yumnam, Ho Jeong Lee, Eun Hee Kim, Won Sup Lee, Sung Chul Shin, Jin A Kim, Sang Joon Lee, Jin Yeul Ma, Taesun Min, Jeong Doo Heo, Gon Sup Kim
      Oncology Letters.2017; 13(4): 2521.     CrossRef
    • Whole-exome sequencing identified mutational profiles of high-grade colon adenomas
      Sung Hak Lee, Seung Jung Hyun, Tae-Min Kim, Je-Keun Rhee, Hyeon-Chun Park, Min Kim Sung, Sung Soo Kim, Chang An Hyeok, Sug Lee Hyung, Yeun-Jun Chung
      Oncotarget.2017; 8(4): 6579.     CrossRef
    • Analysis of prior mammography with negative result in women with interval breast cancer
      Woo Jung Choi, Joo Hee Cha, Hak Hee Kim, Hee Jung Shin, Eun Young Chae
      Breast Cancer.2016; 23(4): 583.     CrossRef
    • Issues in Lung Cancer Screening Among Asian American Immigrants
      Mo-Kyung Sin, Vicky Taylor, Shin-Ping Tu
      Journal of Immigrant and Minority Health.2016; 18(3): 495.     CrossRef
    • Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
      Hong In Yoon, Kyu Hyun Park, Eun-Jung Lee, Ki Chang Keum, Chang Geol Lee, Chul Hoon Kim, Yong Bae Kim
      Cancer Research and Treatment.2016; 48(2): 473.     CrossRef
    • Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer
      Chung Hyun Tae, Jun Haeng Lee, Byung-Hoon Min, Kyoung-Mee Kim, Poong-Lyul Rhee, Jae J Kim
      Gut and Liver.2016; 10(1): 63.     CrossRef
    • Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma
      Sin Woo Lee, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi, Seong Il Seo
      Urology.2016; 90: 119.     CrossRef
    • Oncologic safety of self-expanded metal stent insertion as a bridge to elective surgery in malignant colorectal obstruction
      Se Hui Oh, Nak Jun Choi, Sang Hyuk Seo, Min Sung An, Kwang Hee Kim, Ki Beom Bae, Jin Won Hwang, Sang Heon Lee, Ji Hyun Kim, Sam Ryong Jee, Mi Seon Kang, Kwan Hee Hong
      Korean Journal of Clinical Oncology.2016; 12(1): 48.     CrossRef
    • Different clinical characteristics in sporadic young-age onset colorectal cancer
      Jieun Lee, In-Ho Kim, Jin Su Kim, Sang Woo Kim, Jun Gi Kim, Seung Tack Oh, Won Kyung Kang, Myung Ah Lee
      Medicine.2016; 95(37): e4840.     CrossRef
    • NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer
      Do Youn Park, Chan Choi, Eunji Shin, Jae Hyuk Lee, Chae Hwa Kwon, Hong-Jae Jo, Hyeong-Rok Kim, Hyun Sung Kim, Nahmgun Oh, Ji Shin Lee, Ok Ku Park, Eok Park, Jonghoon Park, Jong-Yeon Shin, Jong-Il Kim, Jeong-Sun Seo, Hee Dong Park, Joonghoon Park
      Oncotarget.2016; 7(7): 8399.     CrossRef
    • MDCT findings of pancreatic metastases according to primary tumors
      Tae Won Choi, Se Hyung Kim, Cheong-Il Shin, Joon Koo Han, Byung Ihn Choi
      Abdominal Imaging.2015; 40(6): 1595.     CrossRef
    • The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population
      Se Young Choi, Hae Jong Kim, Hyun Sub Cheong, Soon Chul Myung
      Korean Journal of Urology.2015; 56(1): 19.     CrossRef
    • Clinical outcomes of endoscopic resection for gastric neoplasms in the pylorus
      Eun Jeong Gong, Do Hoon Kim, Hwoon-Yong Jung, Young Kwon Choi, Hyun Lim, Kwi-Sook Choi, Ji Yong Ahn, Jeong Hoon Lee, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim
      Surgical Endoscopy.2015; 29(12): 3491.     CrossRef
    • T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy
      Min Sung An, Jong Han Yoo, Kwang Hee Kim, Ki Beom Bae, Chang Soo Choi, Jin Won Hwang, Ji Hyun Kim, Bo Mi Kim, Mi Seon Kang, Min Kyung Oh, Kwan Hee Hong
      World Journal of Surgical Oncology.2015;[Epub]     CrossRef
    • Conventional cancer treatment alone or with regional hyperthermia for pain relief in lung cancer: A case–control study
      Yeon-Pyo Kim, Yuri Choi, Sun Kim, Yoon-Sung Park, In-Jae Oh, Kyu-Sik Kim, Young-Chul Kim
      Complementary Therapies in Medicine.2015; 23(3): 381.     CrossRef
    • Association Between Time (Initiation and Length) and Oncological Outcomes for the Patients with Colon Cancer Treated with Adjuvant Chemotherapy
      In Seob Jeong, Jong Han Yoo, Sang Hyuk Seo, Min Sung An, Kwang Hee Kim, Ki Beom Bae, Chang Soo Choi, Jin Won Hwang, Ji Hyun Kim, Mi Seon Kang, Min Kyung Oh, Kwan Hee Hong
      Indian Journal of Surgery.2015; 77(S3): 1252.     CrossRef
    • Effect of patient position on pain scales during transrectal ultrasound-guided prostate biopsy
      Yeong Uk Kim, Yoon Seob Ji, Young Hwii Ko, Phil Hyun Song
      Korean Journal of Urology.2015; 56(6): 449.     CrossRef
    • Comparison of Social Nicotine Dependence Using the KTSND-K Questionnaire between patients with lung cancer and non-cancer people
      Jin Young Lee, Chul Ho Oak, Tae Won Jang, Maan Hong Jung, Seong Jin Nam, Su Kyung Son, Ji Hyun Lee, Eun Joo Jo, Sang Joon Lee
      Kosin Medical Journal.2015; 30(1): 51.     CrossRef
    • ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
      Chee Young Kim, Sang Hyuk Seo, Min Sung An, Kwang Hee Kim, Ki Beom Bae, Jin Won Hwang, Ji Hyun Kim, Bo Mi Kim, Mi Seon Kang, Min Kyung Oh, Kwan Hee Hong
      Annals of Coloproctology.2015; 31(3): 92.     CrossRef
    • Incidence, Trends and Epidemiology of Cancers in North West of Iran
      Atefeh Zahedi, Hosein Rafiemanesh, Mostafa Enayatrad, Mahshid Ghoncheh, Hamid Salehiniya
      Asian Pacific Journal of Cancer Prevention.2015; 16(16): 7189.     CrossRef
    • Hereditary Risk Evaluation for Borderline Ovarian Tumors Based on Immunohistochemistry
      Jung Min Park, Min Kyu Kim
      Journal of Menopausal Medicine.2014; 20(1): 14.     CrossRef
    • Cohort Profile: The Namwon Study and the Dong-gu Study
      S.-S. Kweon, M.-H. Shin, S.-K. Jeong, H.-S. Nam, Y.-H. Lee, K.-S. Park, S.-Y. Ryu, S.-W. Choi, B.-H. Kim, J.-A. Rhee, W. Zheng, J.-S. Choi
      International Journal of Epidemiology.2014; 43(2): 558.     CrossRef
    • Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers
      Yoo Jin Choi, Jae Hwi Song, Jung Hwan Yoon, Won Suk Choi, Suk Woo Nam, Jung Young Lee, Won Sang Park
      Gastric Cancer.2014; 17(2): 247.     CrossRef
    • Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population
      Jong Jin Oh, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong, Chang Wook Jeong, Dokyoon Kim, Hae Jong Kim, Soon Chul Myung
      Gene.2014; 533(1): 86.     CrossRef
    • Perioperative complication and surgical outcome in patients with spine metastases: Retrospective 200-case series in a single institute
      Byung Ho Lee, Jin-Oh Park, Hak-Sun Kim, Young-Chang Park, Hwan-Mo Lee, Seong-Hwan Moon
      Clinical Neurology and Neurosurgery.2014; 122: 80.     CrossRef
    • Economic Burden of Colorectal Cancer in Korea
      Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
      Journal of Preventive Medicine and Public Health.2014; 47(2): 84.     CrossRef
    • Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: A case–control study
      Eun Jeong Gong, Ji Yong Ahn, Hwoon‐Yong Jung, Hyun Lim, Kwi‐Sook Choi, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin‐Ho Kim, Son Yeong Choi, Jae Won Choe, Min‐Ju Kim
      Journal of Gastroenterology and Hepatology.2014; 29(2): 301.     CrossRef
    • Impact of the New International Association for the Study of Lung Cancer Staging System in Non-Small Cell Lung Cancer: With Comparison to the Union for International Cancer Control 6th Tumor, Node, Metastasis Edition
      Myungjae Lee, So Won Lee, Sung Shine Shim, Yon Ju Ryu, Yookyung Kim
      Journal of the Korean Society of Radiology.2014; 70(4): 261.     CrossRef
    • Epidemiologic characteristics of cervical cancer in Korean women
      Hyun-Joo Seol, Kyung-Do Ki, Jong-Min Lee
      Journal of Gynecologic Oncology.2014; 25(1): 70.     CrossRef
    • Performance of 18F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients
      Dong Yun Lee, Chang Hwan Lee, Min Jung Seo, Suk Hyun Lee, Jin-Sook Ryu, Jong Jin Lee
      Annals of Nuclear Medicine.2014; 28(8): 789.     CrossRef
    • Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population
      Hye-Rim Song, Hee Nam Kim, Sun-Seog Kweon, Jin-Su Choi, Hyun Jeong Shim, Sang Hee Cho, Ik Joo Chung, Young-Kyu Park, Soo Hyun Kim, Yoo-Duk Choi, Kyung Woong Joo, Min-Ho Shin
      Tumor Biology.2014; 35(4): 3133.     CrossRef
    • Surgical outcomes of robotic thyroid surgery using a double incision gasless transaxillary approach: Analysis of 400 cases treated by the same surgeon
      Yu‐Mi Lee, Onvox Yi, Tae‐Yon Sung, Ki‐Wook Chung, Jong Ho Yoon, Suck Joon Hong
      Head & Neck.2014; 36(10): 1413.     CrossRef
    • Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population
      Sun-Seog Kweon, Min-Ho Shin, Hee-Nam Kim, Soo-Hyun Kim, Ho-Cheol Kang
      Molecular Biology Reports.2014; 41(6): 3793.     CrossRef
    • Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management
      Hideyuki Akaza, Choung Soo Kim, Peter Carroll, In Young Choi, Byung Ha Chung, Matthew R. Cooperberg, Yoshihiko Hirao, Shiro Hinotsu, Shigeo Horie, Ji Youl Lee, Mikio Namiki, Chi-Fai Ng, Mizuki Onozawa, Seiichiro Ozono, Satoru Ueno, Rainy Umbas, Dingwei Ye
      Prostate International.2014; 2(2): 50.     CrossRef
    • The association between KL polymorphism and prostate cancer risk in Korean patients
      Hae Jong Kim, Jaehyouk Lee, Shin Young Lee, Hyun Sub Cheong, Young-Sik Kye, Wonyong Kim, Seok-Soo Byun, Soon Chul Myung
      Molecular Biology Reports.2014; 41(11): 7595.     CrossRef
    • Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
      Jieun Lee, Tae Ho Hong, In Seok Lee, Young Kyoung You, Myung Ah Lee
      Cancer Research and Treatment.2014; 47(2): 259.     CrossRef
    • Cancer Preventive Potential of Kimchi Lactic Acid Bacteria (Weissella cibaria, Lactobacillus plantarum)
      Shin-Hye Kwak, Young-Mi Cho, Geon-Min Noh, Ae-Son Om
      Journal of Cancer Prevention.2014; 19(4): 253.     CrossRef
    • Comparison of Automated Breast Volume Scanning and Hand-Held Ultrasound in the Detection of Breast Cancer: an Analysis of 5,566 Patient Evaluations
      Woo Jung Choi, Joo Hee Cha, Hak Hee Kim, Hee Jung Shin, Hyunji Kim, Eun Young Chae, Min Ji Hong
      Asian Pacific Journal of Cancer Prevention.2014; 15(21): 9101.     CrossRef
    • Risk Prediction Model for Colorectal Cancer: National Health Insurance Corporation Study, Korea
      Aesun Shin, Jungnam Joo, Hye-Ryung Yang, Jeongin Bak, Yunjin Park, Jeongseon Kim, Jae Hwan Oh, Byung-Ho Nam, Zhengdong Zhang
      PLoS ONE.2014; 9(2): e88079.     CrossRef
    • The Prevalence of Colorectal Adenomas in Asymptomatic Korean Men and Women
      Moon Hee Yang, Sanjay Rampal, Jidong Sung, Yoon-Ho Choi, Hee Jung Son, Jun Haeng Lee, Young-Ho Kim, Dong Kyung Chang, Poong-Lyul Rhee, Jong Chul Rhee, Eliseo Guallar, Juhee Cho
      Cancer Epidemiology, Biomarkers & Prevention.2014; 23(3): 499.     CrossRef
    • Human brucellosis in the People's Republic of China during 2005–2010
      Zhijun Zhong, Shuang Yu, Xichun Wang, Shicun Dong, Jie Xu, Yufei Wang, Zeliang Chen, Zhihua Ren, Guangneng Peng
      International Journal of Infectious Diseases.2013; 17(5): e289.     CrossRef
    • Proteinuria as a Risk Factor for Mortality in Patients with Colorectal Cancer
      Min Jee Kim, Yong Un Kang, Chang Seong Kim, Joon Seok Choi, Eun Hui Bae, Seong Kwon Ma, Sun-Seog Kweon, Soo Wan Kim
      Yonsei Medical Journal.2013; 54(5): 1194.     CrossRef
    • One case of endometrial cancer occurrence: Over 10 years after colon cancer in Lynch family
      Jee Yeon Lee, Hyun Joo Kim, Eun Hee Lee, Hyoun Wook Lee, Jong-Won Kim, Min Kyu Kim
      Obstetrics & Gynecology Science.2013; 56(6): 408.     CrossRef
    • Recent Trends (1991-2010) of Metastatic Skin Cancers in Korea
      Chul Hwan Bang, Jung Min Bae, Hei Sung Kim, Gyeong Mun Kim, Dong Soo Yu, Hyun Jeong Park, Shin Tack Oh, Hoon Kang, Chul Jong Park, Jeong Deuk Lee, Jun Young Lee, Hyung Ok Kim, Young Min Park
      Journal of Korean Medical Science.2013; 28(7): 1083.     CrossRef
    • CD81 is a candidate tumor suppressor gene in human gastric cancer
      Tae-Hyoung Yoo, Byung-Kyu Ryu, Min-Goo Lee, Sung-Gil Chi
      Cellular Oncology.2013; 36(2): 141.     CrossRef
    • Immunogenicity of Influenza Vaccine in Colorectal Cancer Patients
      Dong Ho Kim, Yun Yong Lee, Ui Sup Shin, Sun Mi Moon
      Cancer Research and Treatment.2013; 45(4): 303.     CrossRef
    • Sonographic features and ultrasonography-guided fine-needle aspiration of metastases to the thyroid gland
      Jung Hyun Yoon, Eun-Kyung Kim, Jin Young Kwak, Hee Jung Moon, Ga Ram Kim
      Ultrasonography.2013; 33(1): 40.     CrossRef
    • Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer
      Boram Ha, Hyun Suk Suh, Jihae Lee, Kyung-Ja Lee, Rena Lee, Byung In Moon
      Radiation Oncology Journal.2013; 31(4): 191.     CrossRef
    • Effect of multiple invasive foci on breast cancer outcomes according to the molecular subtypes: a report from the Korean Breast Cancer Society
      H.G. Moon, W. Han, J.Y. Kim, S.J. Kim, J.H. Yoon, S.J. Oh, J.H. Yu, D.Y. Noh
      Annals of Oncology.2013; 24(9): 2298.     CrossRef
    • Preoperative Factors Predictive of Posterolateral Extracapsular Extension After Radical Prostatectomy
      Sahyun Pak, Sejun Park, Jeman Ryu, Sungwoo Hong, Sang Hoon Song, Dalsan You, In Gab Jeong, Cheryn Song, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn
      Korean Journal of Urology.2013; 54(12): 824.     CrossRef
    • Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population
      Hye‐Rim Song, Hee Nam Kim, Sun‐Seog Kweon, Jin‐Su Choi, Hyun Jeong Shim, Sang Hee Cho, Ik Joo Chung, Young‐Kyu Park, Soo Hyun Kim, Yoo‐Duk Choi, Kyung Woong Joo, Min‐Ho Shin
      Molecular Carcinogenesis.2013; 52(S1): 155.     CrossRef
    • Current status of chemotherapy for the treatment of advanced biliary tract cancer
      Takashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, Kazuhiko Koike
      The Korean Journal of Internal Medicine.2013; 28(5): 515.     CrossRef
    • Lung Cancer Incidence by Smoking Status in Korean Men: 16-Years of Observations in the Seoul Male Cancer Cohort Study
      Jong-Myon Bae, Zhong-Min Li, Myung-Hee Shin, Dong-Hyun Kim, Moo-Song Lee, Yoon-Ok Ahn
      Journal of Korean Medical Science.2013; 28(4): 636.     CrossRef
    • Methods and Clinical Efficacy of Dosimetry-Based Treatment in Radioiodine Therapy of Thyroid Cancer
      Jin Chul Paeng, June-Key Chung
      Journal of Korean Thyroid Association.2013; 6(1): 43.     CrossRef
    • Korean Prostate Cancer Patients Have Worse Disease Characteristics than their American Counterparts
      Dong Il Kang, Jae Il Chung, Hong Koo Ha, Kweonsik Min, Jangho Yoon, Wansuk Kim, Won Ik Seo, Pil Moon Kang, Soo Jin Jung, Isaac Yi Kim
      Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6913.     CrossRef
    • GKN1 and miR-185 are associated with CpG island methylator phenotype in gastric cancers
      Byung Joon Choi, Jung Hwan Yoon, Won Suk Choi, Olga Kim, Suk Woo Nam, Jung Young Lee, Won Sang Park
      Molecular & Cellular Toxicology.2013; 9(3): 227.     CrossRef
    • Naked Cuticle Drosophila 1 Expression in Histologic Subtypes of Small Adenocarcinoma of the Lung
      Sangjeong Ahn, Won Hwangbo, Hyunchul Kim, Chul Hwan Kim
      Korean Journal of Pathology.2013; 47(3): 211.     CrossRef
    • Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
      Sungwoo Hong, In Gab Jeong, Dalsan You, Jae-Lyun Lee, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
      Journal of Korean Medical Science.2013; 28(5): 687.     CrossRef
    • Current Status of 5α-Reductase Inhibitors in Prostate Disease Management
      Dong Il Kang, Jae Il Chung
      Korean Journal of Urology.2013; 54(4): 213.     CrossRef
    • Pathway-Based Analysis Using Genome-wide Association Data from a Korean Non-Small Cell Lung Cancer Study
      Donghoon Lee, Geon Kook Lee, Kyong-Ah Yoon, Jin Soo Lee, William C. S. Cho
      PLoS ONE.2013; 8(6): e65396.     CrossRef
    • Epstein-Barr Virus-Encoded BARF1 Promotes Proliferation of Gastric Carcinoma Cells through Regulation of NF-κB
      Mee Soo Chang, Dong Ha Kim, Jin Kyung Roh, Jaap M. Middeldorp, Yang Soo Kim, Sunghan Kim, Seungbong Han, Chul Woo Kim, Byung Lan Lee, Woo Ho Kim, Jun Hee Woo
      Journal of Virology.2013; 87(19): 10515.     CrossRef
    • Mortality and Potential Years of Life Lost of Colorectal cancer between Korea and OECD countries before and after the year 2000
      Dong-Seok Kim, Soo-Won Kang
      Journal of the Korea Academia-Industrial cooperation Society.2012; 13(11): 5261.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Prediction of Cancer Incidence and Mortality in Korea, 2012
      Cancer Res Treat. 2012;44(1):25-31.   Published online March 31, 2012
      DOI: https://doi.org/10.4143/crt.2012.44.1.25
      Close
    • XML DownloadXML Download
    • 0
    • 1
    • 2
    Prediction of Cancer Incidence and Mortality in Korea, 2012
    Image Image Image
    Fig. 1 The 10 leading types of estimated new cancer cases and deaths by gender in 2012. (A) Estimated new cases. (B) Estimated deaths.
    Fig. 2 Projected age-specific incidences of major cancers during 2012 in Korea. (A) Male. (B) Female.
    Fig. 3 Projected age-specific mortality rates of major cancers during 2012 in Korea. (A) Male. (B) Female.

    Fig. 1

    Fig. 2

    Fig. 3

    Prediction of Cancer Incidence and Mortality in Korea, 2012
    Sites Estimated new cases
    		 Estimated deaths
    Both genders Male Female Both genders Male Female
    All sites 234,727 118,304 116,423 73,313 45,356 27,957
    Lip, oral cavity, and pharynx 2,801 2,102 699 1,024 754 270
    Esophagus 2,262 2,075 187 1,223 1,139 84
    Stomach 32,455 22,054 10,401 8,685 5,630 3,055
    Colon and rectum 32,215 19,669 12,546 8,195 4,648 3,547
    Liver 16,910 12,585 4,325 10,973 8,186 2,787
    Gallbladdera) 5,481 2,697 2,784 3,884 1,879 2,005
    Pancreas 5,396 2,911 2,485 4,663 2,445 2,218
    Larynx 1,077 1,036 41 226 210 16
    Lung 22,737 15,991 6,746 16,168 11,819 4,349
    Breast 16,436 63 16,373 2,146 16 2,130
    Cervix uteri 3,292 - 3,292 819 - 19
    Corpus uteri 2,085 - 2,085 259 - 259
    Ovary 2,124 - 2,124 987 - 987
    Prostate 11,016 11,016 - 1,540 1,540 -
    Testis 215 215 - 18 18 -
    Kidney 4,310 2,949 1,361 846 558 288
    Bladder 3,969 3,185 784 1,026 737 289
    Brain and CNS 1,837 975 862 1,061 575 486
    Thyroid 46,021 7,158 38,863 360 100 260
    Hodgkin lymphoma 253 160 93 41 26 15
    Non-Hodgkin lymphoma 4,506 2,502 2,004 1,493 865 628
    Multiple myeloma 1,236 648 588 841 424 417
    Leukemia 2,885 1,609 1,276 1,676 964 712
    Other and ill defined 13,208 6,704 6,504 5,159 2,823 2,336
    Crude incidence rates/100,000
    		 Age-standardized incidence rates/100,000a)
    Both genders Male Female Both genders Male Female
    All sites 462.7 465.6 459.7 312.5 345.1 300.9
    Lip, oral cavity, and pharynx 5.5 8.3 2.8 3.8 6.0 1.9
    Esophagus 4.5 8.2 0.7 2.9 6.1 0.4
    Stomach 64.0 86.8 41.1 42.1 63.2 24.7
    Colon and rectum 63.5 77.4 49.5 41.9 56.7 29.5
    Liver 33.3 49.5 17.1 22.0 35.6 10.0
    Gallbladderb) 10.8 10.6 11.0 6.7 7.9 5.7
    Pancreas 10.6 11.5 9.8 6.7 8.4 5.3
    Larynx 2.1 4.1 0.2 1.4 3.0 0.1
    Lung 44.8 62.9 26.6 28.2 46.6 14.7
    Breast 32.4 0.2 64.6 22.2 0.2 44.1
    Cervix uteri 6.5 - 13.0 4.4 - 8.5
    Corpus uteri 4.1 - 8.2 2.8 - 5.5
    Ovary 4.2 - 8.4 3.0 - 5.8
    Prostate 21.7 43.4 - 14.1 32.5 -
    Testis 0.4 0.8 - 0.4 0.8 -
    Kidney 8.5 11.6 5.4 5.9 8.5 3.5
    Bladder 7.8 12.5 3.1 4.9 9.2 1.6
    Brain and CNS 3.6 3.8 3.4 3.1 3.4 2.7
    Thyroid 90.7 28.2 153.4 64.5 20.1 109.4
    Hodgkin lymphoma 0.5 0.6 0.4 0.4 0.5 0.3
    Non-Hodgkin lymphoma 8.9 9.8 7.9 6.4 7.7 5.4
    Multiple myeloma 2.4 2.6 2.3 1.6 1.9 1.4
    Leukemia 5.7 6.3 5.0 5.1 6.0 4.4
    Other and ill defined 26.0 26.4 25.7 18.1 20.7 15.9
    Rank Age group (yr)
    0-14 15-34 35-64 ≥65
    Male
    1 Leukemia Thyroid Stomach Lung
    (4.9) (12.2) (98.2) (479.0)
    2 Brain and CNS Leukemia Colon and rectum Stomach
    (2.4) (3.2) (86.6) (449.8)
    3 Non-Hodgkin lymphoma Non-Hodgkin lymphoma Liver Colon and rectum
    (1.8) (2.9) (65.9) (404.0)
    4 Kidney Colon and rectum Thyroid Prostate
    (0.5) (2.8) (47.9) (350.5)
    5 Testis Stomach Lung Liver
    (0.4) (2.5) (41.3) (207.2)
    Female
    1 Leukemia Thyroid Thyroid Colon and rectum
    (4.0) (68.5) (272.4) (198.8)
    2 Brain and CNS Breast Breast Stomach
    (2.0) (11.2) (119.4) (154.9)
    3 Non-Hodgkin lymphoma Cervix uteri Colon and rectum Lung
    (1.0) (4.9) (49.9) (129.8)
    4 Ovary Stomach Stomach Thyroid
    (0.7) (4.3) (43.1) (96.5)
    5 Kidney Colon and rectum Lung Liver
    (0.5) (2.7) (20.6) (76.7)
    Sites Crude incidence rates/100,000
    		 Age-standardized incidence rates/100,000a)
    Both genders Male Female Both genders Male Female
    All sites 144.5 178.5 110.4 89.7 132.8 59.0
    Lip, oral cavity, and pharynx 2.0 3.0 1.1 1.3 2.1 0.6
    Esophagus 2.4 4.5 0.3 1.5 3.3 0.1
    Stomach 17.1 22.2 12.1 10.4 16.4 6.1
    Colon and rectum 16.2 18.3 14.0 9.8 13.7 7.1
    Liver 21.6 32.2 11.0 14.0 23.5 6.0
    Gallbladderb) 7.7 7.4 7.9 4.5 5.5 3.8
    Pancreas 9.2 9.6 8.8 5.7 7.1 4.5
    Larynx 0.4 0.8 0.1 0.3 0.6 0.0
    Lung 31.9 46.5 17.2 19.3 34.4 8.7
    Breast 4.2 0.1 8.4 2.8 0.0 5.4
    Cervix uteri 1.6 - 3.2 1.0 - 1.8
    Corpus uteri 0.5 - 1.0 0.3 - 0.6
    Ovary 1.9 - 3.9 1.2 - 2.3
    Prostate 3.0 6.1 - 1.7 4.7 -
    Testis 0.0 0.1 - 0.0 0.1 -
    Kidney 1.7 2.2 1.1 1.0 1.6 0.6
    Bladder 2.0 2.9 1.1 1.1 2.2 0.5
    Brain and CNS 2.1 2.3 1.9 1.5 1.8 1.3
    Thyroid 0.7 0.4 1.0 0.4 0.3 0.5
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 2.9 3.4 2.5 1.9 2.6 1.3
    Multiple myeloma 1.7 1.7 1.6 1.0 1.2 0.9
    Leukemia 3.3 3.8 2.8 2.4 3.0 1.9
    Other and ill defined 10.2 11.1 9.2 6.4 8.4 5.0
    Table 1 Estimated new cancer cases and deaths by gender during 2012 in Korea

    CNS, central nervous system. a)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 2 Estimated crude and age-standardized cancer incidences by gender during 2012 in Korea

    CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

    Table 3 Estimated cancer incidence by age group and sex during 2012 in Korea

    CNS, central nervous system.

    Table 4 Estimated crude and age-standardized cancer mortality rates by gender during 2012 in Korea

    CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of biliary tract.

    Table 1

    Table 2

    Table 3

    Table 4

    Cancer Res Treat : Cancer Research and Treatment
    © Korean Cancer Association.
    Close layer
    TOP